Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

The Treatment of Hypercholesterolemia: A Managed Care Perspective

Goals and Objectives

By

September 1st 1997

Introduction

ByIra Weg, MD,Gary Gerstenblith, MD

September 1st 1997

The Rationale for Treating Hypercholesterolemia

ByWilliam R. Garnett, PharmD

September 1st 1997

Lowering Risk Factors through Cholesterol Treatment: Overview of the Recent Major Trials

BySidney C. Smith, Jr, MD

September 1st 1997

Preventing Coronary Heart Disease in the Managed Care Era: Improving the Cost Effectiveness of Lipid-Lowering Therapy with HMG-CoA Reductase Inhibitors

ByTerry A. Jacobson, MD

September 1st 1997

Treating Hyperlipidemia to Prevent Coronary Heart Disease: What Are the Treatment Goals and How Do We Get There?

ByChristie M. Ballantyne, MD

September 1st 1997

Managing Comorbidities through Cholesterol-Lowering

ByAlan O. Marcus, MD

September 1st 1997

CME Quiz

By

September 1st 1997

Selected Abstracts

By

September 1st 1997

Bibliography

By

September 1st 1997

Participants

By

September 1st 1997

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD

Nutrition in Pregnancy May Shape Metabolic Health After Delivery